We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




New Genetic Test Predicts Obesity in Childhood

By LabMedica International staff writers
Posted on 22 Jul 2025

Obesity is a rapidly growing global health issue, with the World Obesity Federation projecting that more than half the world's population will be overweight or obese by 2035. More...

Current treatment options such as lifestyle changes, surgery, and medication are not universally effective or accessible. Moreover, identifying individuals at high risk early enough to prevent the onset of obesity remains a major challenge. Subtle variations in our genomes play a role in increasing susceptibility to obesity, especially through mechanisms like appetite regulation in the brain. Early identification of genetic risk before physical symptoms develop could help enable preventive strategies. Now, a new genetic approach offers the ability to identify children at high risk for obesity well before their weight is affected, potentially opening the door to earlier and more effective interventions.

Researchers from the University of Copenhagen (Copenhagen, Denmark) and the University of Bristol (Bristol, UK) have developed a new polygenic score (PGS) to predict obesity risk. The PGS was created using the genetic data of over five million people, the largest and most diverse dataset of its kind. The score aggregates the effects of thousands of individual genetic variants linked to obesity and calculates an overall risk value for each person. The researchers tested the PGS using data from more than 500,000 individuals and explored its predictive power through the lens of both physical traits and genetic profiles. They also examined how heart health indicators like BMI, sex, and hypertension influence risk. The work draws on contributions from over 600 scientists across 500 institutions globally, as part of a broader effort to understand anthropometric traits such as BMI and height.

The PGS was found to be twice as effective as previous best-in-class tests for predicting obesity risk. It was also particularly effective in identifying genetic risk in early childhood, even before the age of five. The findings, published in Nature Medicine, show that individuals with higher genetic risk scores responded more strongly to lifestyle-based weight loss interventions like diet and exercise but they also tended to regain weight more quickly once those interventions stopped. However, a key limitation remains: the PGS was significantly more accurate in people of European ancestry than those of African ancestry, despite the use of a more globally representative genetic dataset. Moving forward, the researchers aim to refine the model to improve its predictive power across more diverse populations and continue exploring its use in early prevention strategies.

"This new polygenic score is a dramatic improvement in predictive power and a leap forward in the genetic prediction of obesity risk, which brings us much closer to clinically useful genetic testing," said Professor Ruth Loos, senior author of the study.


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
Thyroid Test
Anti-Thyroid EIA Test
Automatic CLIA Analyzer
Shine i6000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: Shutterstock

Blood Test Could Guide Drug Selection to Prevent Repeat Heart Attacks and Strokes

Secondary prevention after myocardial infarction or stroke relies on antiplatelet therapy, yet responses vary widely and both recurrent thrombosis and bleeding remain persistent risks. In the United Kingdom,... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Type 1 diabetes affects more than 9 million people worldwide and can begin years before symptoms appear, making early identification of at-risk children difficult (Image Credit: iStock)

Early-Life Gut Microbiome Changes May Help Assess Type 1 Diabetes Risk

Type 1 diabetes (T1D) affects more than 9 million people worldwide, including 1.8 million children and adolescents, and often begins years before symptoms appear. Early identification of children who are... Read more

Pathology

view channel
Image: A new study demonstrates that vascular features in colorectal tumors could serve as prognostic biomarkers of disease outcome. (Image Credit: iStock)

Tumor Blood Vessel Features May Help Predict Colorectal Cancer Survival

Colorectal cancer outcomes vary widely, and tumor biology remains a key determinant of prognosis. Because neoplasms depend on a vascular supply, differences in intratumoral vessels may influence survival.... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: Central to the collaboration is the Enhanced Liver Fibrosis (ELF) test, a noninvasive blood test authorized in the U.S. to assess disease progression risk in patients with advanced fibrosis due to MASH and support patient management decisions. (Photo courtesy of Siemens Healthineers)

Siemens Healthineers and Novo Collaborate to Expand Access to Noninvasive Liver Testing

Metabolic dysfunction‑associated steatotic liver disease (MASLD) and its progressive form, metabolic dysfunction‑associated steatohepatitis (MASH), affect millions and are linked to obesity, type 2 diabetes,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.